中文名称: | 小檗碱 促销 | ||||
---|---|---|---|---|---|
英文名称: | Berberine | ||||
别名: | 黄连素 Berberine | ||||
CAS No: | 2086-83-1 | 分子式: | C20H18NO4+ | 分子量: | 336.37 |
CAS No: | 2086-83-1 | ||||
分子式: | C20H18NO4+ | ||||
分子量: | 336.37 | ||||
MDL: | MFCD01175817 | EINEC: | 218-229-1 | ||
EINEC: | 218-229-1 |
基本信息
产品编号: |
B10114 |
||||
产品名称: |
Berberine |
||||
CAS: |
2086-83-1 |
储存条件 |
粉末 |
2-8℃ |
四年 |
|
|
||||
分子式: |
溶于液体 |
-80℃ |
两年 |
||
分子量 |
336.37 |
|
|
||
化学名: |
9,10-dimethoxy-5,6-dihydro[1,3]dioxolo[4,5-g]isoquino[3,2-a]isoquinolin-7-ium |
||||
Solubility (25°C): |
|||||
体外:
|
DMSO |
22.5mg/mL(66.89mM) |
|||
Ethanol |
5mg/mL(14.86mM) |
||||
Water |
1mg/mL(2.97mM) |
||||
体内(现配现用): |
|
||||
<1mg/ml表示微溶或不溶。 |
|||||
普西唐提供的所有化合物浓度为内部测试所得,实际溶液度可能与公布值有所偏差,属于正常的批间细微差异现象。 |
|||||
请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;⼀旦配成溶液,请分装保存,避免反复冻融造成的产品失效。 |
制备储备液
浓度
溶液体积 质量 |
1mg |
5mg |
10mg |
1mM |
2.9730mL |
14.8650mL |
29.7301mL |
5mM |
0.5946mL |
2.9730mL |
5.9460mL |
10mM |
0.2973mL |
1.4865mL |
2.9730mL |
50mM |
0.0595mL |
0.2973mL |
0.5946mL |
生物活性
产品描述 |
Berberine (Natural Yellow 18) 是从中草药⻩连中分离出来的⼀种⽣物碱,常⽤作抗⽣素。Berberine (Natural Yellow 18) 诱 导活性氧 (ROS) ⽣成并抑制 DNA 拓扑异构酶 (topoisomerase)。Berberine (Natural Yellow 18) 具有抗肿瘤特性。 |
|
靶点 |
Human Endogenous Metabolite |
|
体外研究 |
Berberine (1.25-160μM; 72 hours) has potential inhibitory effects on the proliferation of four colorectal carcinoma cell lines LoVo, HCT116, SW480, and HT-29. Berberine (1.25-160μM; 24-72 hours) induces a time- and dose-dependent inhibition of LoVo cell growth. LoVo cells are exposure to Berberine (10-80μM) for 24 h. Cell cycle analysis of 40μM Berberine-treated LoVo cells by flow cytometry shows accumulation of cells in the G2/M phase. Berberine (10-80μM) suppresses cyclin B1, cdc2 and cdc25c protein expression after 24 h, especially at the dose of 80.0μM Cell Proliferation Assay |
|
Cell Line: |
Four colorectal carcinoma cell lines LoVo, HCT116, SW480, and HT-29 |
|
Concentration: |
1.25, 2.5, 5, 10, 20, 40, 80, and 160μM |
|
Incubation Time: |
72 hours |
|
Result: |
Inhibited the proliferation of four cell lines. The IC50 ranged from 40.8±4.1μM (LoVo) to 98.6±2.9μM (HCT116). |
|
Cell Proliferation Assay |
||
Cell Line: |
Colorectal carcinoma cell lines LoVo |
|
Concentration: |
1.25, 2.5, 5, 10, 20, 40, 80, and 160μM |
|
Incubation Time: |
24, 48, 72 hours |
|
Result: |
Induced a time- and dose-dependent inhibition of cell growth. By 72 h, 160.0μM induced 71.1±1.9 % growth inhibitions in LoVo cells. |
|
Cell Cycle Analysis |
||
Cell Line: |
LoVo cells |
|
Concentration: |
0, 10, 20, 40, or 80μM |
|
Incubation Time: |
24 hours |
|
Result: |
Exposure to 40.0μM induced G2/M-phase cell cycle arrest, an increase in the G2/M-phase population and a progressive decline in the G1 population. |
|
Western Blot Analysis |
||
Cell Line: |
LoVo cells |
|
Concentration: |
10, 20, 40, or 80μM |
|
Incubation Time: |
24 hours |
|
Result: |
Suppressed cyclin B1, cdc2 and cdc25c protein expression. |
|
体内研究 |
Berberine (10, 30, or 50mg/kg/day; gastrointestinal gavage; for 10 consecutive days) inhibits the growth of human colorectal adenocarcinoma in vivo. Berberine at doses of 30 and 50mg/kg/day taken by gastrointestinal gavage shows inhibitory rates of 33.1% and 45.3% on the human colorectal adenocarcinoma xenograft growth in nude mice |
|
Animal Model: |
5-week-old BALB/c nu/nu mice with human colorectal adenocarcinoma LoVo xenografts |
|
Dosage: |
10, 30, or 50mg/kg/day |
|
Administration: |
Gastrointestinal gavage; for 10 consecutive days |
|
Result: |
Showed inhibitory rates of 33.1 % and 45.3 % at doses of 30 and 50mg/kg/day. |
本计算器可帮助您计算出特定溶液中溶质的质量、溶液浓度和体积之间的关系,公式为:
质量 (g) = 浓度 (mol/L) x 体积 (L) x 分子量 (g/mol)
摩尔浓度计算公式
用本工具协助配置特定浓度的溶液,使用的计算公式为:
开始浓度 x 开始体积 = 最终浓度 x 最终体积
稀释公式
稀释公式一般简略地表示为:C1V1 = C2V2 ( 输入 输出 )